MCM
ALXN

Munder Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Munder Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$7.7M Hold
46,415
– – 0.06% 265
2014
Q2 		$7.25M Buy
46,415
+5,085
+12% +$803K 0.05% 265
2014
Q1 		$6.29M Sell
41,330
-8,005
-16% -$1.27M 0.05% 289
2013
Q4 		$6.56M Sell
49,335
-55
-0.1% -$6.6K 0.05% 285
2013
Q3 		$5.74M Sell
49,390
-30
-0.1% -$3.29K 0.05% 288
2013
Q2 		$4.56M Buy
+49,420
New +$4.76M 0.04% 297

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Munder Capital Management's ALXN Position: Q3 2014 in Review

Munder Capital Management held its Alexion Pharmaceuticals (ALXN) position steady in Q3 2014 at 46,415 shares worth $7.7M. The position accounts for 0.06% of the portfolio, ranked #265.

Munder Capital Management first reported a position in ALXN in Q2 2013 and has held it in 6 quarters since. 522 funds tracked by Wall St. Rank hold ALXN as of Q3 2014.

  • Munder Capital Management held 46,415 shares of Alexion Pharmaceuticals worth $7.7M as of Q3 2014.
  • Munder Capital Management left its Alexion Pharmaceuticals share count unchanged in Q3 2014.
  • Alexion Pharmaceuticals made up 0.06% of Munder Capital Management's portfolio in Q3 2014, its #265 holding.
  • Munder Capital Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
  • 522 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.